{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T17:47:00Z","timestamp":1792432020746,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81570337"],"award-info":[{"award-number":["81570337"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81570416"],"award-info":[{"award-number":["81570416"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81974032"],"award-info":[{"award-number":["81974032"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003172","name":"Henan University of Science and Technology","doi-asserted-by":"publisher","award":["2017060201010175"],"award-info":[{"award-number":["2017060201010175"]}],"id":[{"id":"10.13039\/501100003172","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003172","name":"Henan University of Science and Technology","doi-asserted-by":"publisher","award":["2017KFYXJJ099"],"award-info":[{"award-number":["2017KFYXJJ099"]}],"id":[{"id":"10.13039\/501100003172","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["2019CFB668"],"award-info":[{"award-number":["2019CFB668"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["YXQN009"],"award-info":[{"award-number":["YXQN009"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.ejphar.2020.173822","type":"journal-article","created":{"date-parts":[[2020,12,22]],"date-time":"2020-12-22T22:40:16Z","timestamp":1608676816000},"page":"173822","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Bazedoxifene exhibits anti-inflammation and anti-atherosclerotic effects via inhibition of IL-6\/IL-6R\/STAT3 signaling"],"prefix":"10.1016","volume":"893","author":[{"given":"Pengcheng","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yina","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongqiang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianshu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengqi","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moran","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenglong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayuh","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiagao","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuntai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ejphar.2020.173822_bib1","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3389\/fcvm.2017.00084","article-title":"An interleukin-6 receptor antibody suppresses atherosclerosis in atherogenic mice","volume":"22","author":"Akita","year":"2017","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.ejphar.2020.173822_bib2","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1182\/blood-2010-06-291245","article-title":"IL-6 in human cytomegalovirus secretome promotes angiogenesis and survival of endothelial cells through the stimulation of survivin","volume":"117","author":"Botto","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2020.173822_bib3","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1161\/CIRCRESAHA.108.175976","article-title":"Chronic apoptosis of vascular smooth muscle cells accelerates atherosclerosis and promotes calcification and medial degeneration","volume":"102","author":"Clarke","year":"2008","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2020.173822_bib4","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1084\/jem.180.4.1243","article-title":"Defective inflammatory response in interleukin 6-deficient mice","volume":"180","author":"Fattori","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ejphar.2020.173822_bib5","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1161\/CIRCRESAHA.115.306301","article-title":"Endothelial cell dysfunction and the pathobiology of atherosclerosis","volume":"118","author":"Gimbrone","year":"2016","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.ejphar.2020.173822_bib6","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jhep.2019.10.028","article-title":"A defect in endothelial autophagy occurs in patients with nonalcoholic steatohepatitis and promotes inflammation and fibrosis","volume":"72","author":"Hammoutene","year":"2020","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.ejphar.2020.173822_bib7","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/CRD.0000000000000021","article-title":"Inflammation and atherosclerosis: a review of the role of interleukin-6 in the development of atherosclerosis and the potential for targeted drug therapy","volume":"22","author":"Hartman","year":"2014","journal-title":"Cardiol. Rev."},{"key":"10.1016\/j.ejphar.2020.173822_bib8","doi-asserted-by":"crossref","DOI":"10.1172\/JCI121208","article-title":"High-fat diet exacerbates SIV pathogenesis and accelerates disease progression","author":"He","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2020.173822_bib9","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2174\/157340308785160570","article-title":"Roles of IL-6-gp130 signaling in vascular inflammation","volume":"4","author":"Hou","year":"2008","journal-title":"Curr. Cardiol. Rev."},{"issue":"5","key":"10.1016\/j.ejphar.2020.173822_bib10","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1089\/jir.2005.25.241","article-title":"IL-6 transsignaling: the in vivo consequences","volume":"25","author":"Jones","year":"2005","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.ejphar.2020.173822_bib11","first-page":"651","article-title":"Looking back and thinking forwards - 15 years of cardiology and cardiovascular research","volume":"16","author":"Kalman","year":"2019"},{"issue":"3","key":"10.1016\/j.ejphar.2020.173822_bib12","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1021\/jm401144z","article-title":"Drug design targeting protein-protein interactions (PPIs) using multiple ligand simultaneous docking (MLSD) and drug repositioning: discovery of raloxifene and Bazedoxifene as novel inhibitors of IL-6\/GP130 interface","volume":"13","author":"Li","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2020.173822_bib13","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/j.jacc.2019.07.061","article-title":"From focal lipid storage to systemic inflammation: JACC review topic of the week","volume":"74","author":"Libby","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.ejphar.2020.173822_bib14","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.atherosclerosis.2015.04.014","article-title":"Circulating levels of interleukin 6 soluble receptor and its natural antagonist, sgp130, and the risk of myocardial infarction","volume":"240","author":"Moreno Velasquez","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ejphar.2020.173822_bib15","first-page":"984","article-title":"The association between dietary fibre deficiency and high-income lifestyle-associated diseases: burkitt's hypothesis revisited. The lancet","volume":"4","author":"O'Keefe","year":"2019","journal-title":"Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2020.173822_bib16","first-page":"752","article-title":"Low-dose methotrexate for the prevention of atherosclerotic events","volume":"380","author":"Ridker","year":"2019"},{"issue":"4","key":"10.1016\/j.ejphar.2020.173822_bib17","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.ahj.2011.06.012","article-title":"Interleukin-1beta inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)","volume":"162","author":"Ridker","year":"2011","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ejphar.2020.173822_bib18","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2020.173822_bib19","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/S0140-6736(17)32247-X","article-title":"Effect of interleukin-1beta inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial","volume":"390","author":"Ridker","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2020.173822_bib20","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.atherosclerosis.2015.01.029","article-title":"A score including ADAM17 substrates correlates to recurring cardiovascular event in subjects with atherosclerosis","volume":"239","author":"Rizza","year":"2015","journal-title":"Atherosclerosis"},{"issue":"10","key":"10.1016\/j.ejphar.2020.173822_bib21","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.jacc.2019.07.043","article-title":"Epigenetic modification in coronary atherosclerosis: JACC review topic of the week","volume":"74","author":"Rizzacasa","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2020.173822_bib22","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/j.jacc.2019.08.1017","article-title":"Chronic kidney disease and coronary artery disease: JACC state-of-the-art review","volume":"74","author":"Sarnak","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2020.173822_bib23","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1161\/ATVBAHA.111.229435","article-title":"Transsignaling of interleukin-6 crucially contributes to atherosclerosis in mice","volume":"32","author":"Schuett","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejphar.2020.173822_bib24","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.bbrc.2017.07.067","article-title":"Inhibition of IL-6\/STAT3 signaling in human cancer cells using Evista","volume":"491","author":"Shi","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2020.173822_bib25","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","author":"Tardif","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2020.173822_bib26","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1016\/j.jacc.2017.01.060","article-title":"Detection of atherosclerotic inflammation by (68)Ga-DOTATATE PET compared to [(18)F]FDG PET imaging","volume":"69","author":"Tarkin","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2020.173822_bib27","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1158\/0008-5472.CAN-16-2446","article-title":"Soluble IL6R expressed by myeloid cells reduces tumor-specific Th1 differentiation and drives tumor progression","volume":"77","author":"Tsukamoto","year":"2017","journal-title":"Canc. Res."},{"key":"10.1016\/j.ejphar.2020.173822_bib28","doi-asserted-by":"crossref","first-page":"33683","DOI":"10.18632\/oncotarget.16898","article-title":"Growth-suppressive activity of raloxifene on liver cancer cells by targeting IL-6\/GP130 signaling","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejphar.2020.173822_bib29","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1161\/01.RES.0000194331.76925.5c","article-title":"Increased neointima formation in cysteine-rich protein 2-deficient mice in response to vascular injury","volume":"97","author":"Wei","year":"2005","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.ejphar.2020.173822_bib30","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1161\/CIRCRESAHA.118.313591","article-title":"Immunity and inflammation in atherosclerosis","volume":"124","author":"Wolf","year":"2019","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2020.173822_bib31","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1158\/1535-7163.MCT-15-0921","article-title":"Bazedoxifene as a novel GP130 inhibitor for pancreatic cancer therapy","volume":"15","author":"Wu","year":"2016","journal-title":"Mol. Canc. Therapeut."},{"key":"10.1016\/j.ejphar.2020.173822_bib32","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1093\/eurheartj\/ehz303","article-title":"The novel coronary artery disease risk gene JCAD\/KIAA1462 promotes endothelial dysfunction and atherosclerosis","volume":"40","author":"Xu","year":"2019","journal-title":"Eur. Heart J."},{"issue":"3","key":"10.1016\/j.ejphar.2020.173822_bib33","article-title":"Smooth muscle-selective inhibition of nuclear factor-kappaB attenuates smooth muscle phenotypic switching and neointima formation following vascular injury","volume":"2","author":"Yoshida","year":"2013","journal-title":"J. Am. Heart Ass."},{"key":"10.1016\/j.ejphar.2020.173822_bib34","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.cmet.2019.09.016","article-title":"Adipocyte hypoxia-inducible factor 2alpha suppresses atherosclerosis by promoting adipose ceramide catabolism","volume":"30","author":"Zhang","year":"2019","journal-title":"Cell Metabol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920309274?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920309274?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:43:45Z","timestamp":1757976225000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299920309274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":34,"alternative-id":["S0014299920309274"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.173822","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bazedoxifene exhibits anti-inflammation and anti-atherosclerotic effects via inhibition of IL-6\/IL-6R\/STAT3 signaling","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.173822","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"173822"}}